Akira Dejima

Tokyo Metropolitan Komagome Hospital

Papers

2

Total Citations

5

H-Index

2

About

Akira Dejima is a surgical oncologist whose work focuses on improving outcomes in colorectal cancer surgery, with particular expertise in minimally invasive techniques and the management of chemotherapy-related complications. His research addresses critical challenges in postoperative recovery and patient safety, including the prevention of incisional hernias following colectomy. In a 2024 study, Dejima demonstrated that using a Pfannenstiel incision for specimen extraction during laparoscopic or robotically assisted colectomy significantly reduces incisional hernia incidence compared to traditional midline incisions—a practical finding that directly informs surgical decision-making. He also documented a rare case of localized peliosis hepatis mimicking liver metastasis during oxaliplatin-based adjuvant chemotherapy, highlighting his ability to identify and characterize unusual treatment-related pathologies. While his citation counts are still building, Dejima’s work represents important contributions to the evidence base for colorectal surgery, bridging the gap between technical innovation and clinical complication management. His research is particularly valuable for surgeons seeking to refine their approach to minimally invasive colectomy and for oncologists monitoring chemotherapy side effects.

Research Focus

Key Achievements

2
H-Index
2
Papers
5
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
A rare case of localized peliosis hepatis during adjuvant chemotherapy including oxaliplatin mimicking a liver metastasis of colon cancer
3 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Tokyo Metropolitan Komagome Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago